Roche chairman says Illumina bid off the table: paper
ZURICH (Reuters) – Swiss pharmaceutical group Roche is no longer considering a bid for U. S. gene-sequencing company Illumina , Chairman Franz Humer was quoted as saying in a newspaper interview on Sunday. “Illumina is definitely off the table. They were not willing to abandon the totally unrealistic price they were asking for. Roche does not do acquisitions that don’t create value,” he told Swiss paper SonntagsZeitung. Roche walked away from a $6. 8 billion bid for Illumina in April after shareholders blocked its move to gain seats on the U. S. . . .
View full post on Business News Headlines – Yahoo! News
Leave a Reply